炎症性肠病患者静脉血栓栓塞发病率仍居高不下:一项基于人群的研究
该研究利用加拿大曼尼托巴大学IBD流行病学数据库(1984-2018)发现,IBD患者VTE发生率为7.6%,显著高于对照组的3.3%(P<0.0001);年龄标化发病率在IBD为433/10万,对照组为184/10万,发病率比为2.36(95%CI 2.16-2.58)。尽管30年来IBD管理有所进步,VTE发生率仅以每年-0.7%的速度缓慢下降(P=0.0003),仍显著高于对照人群。
要点
- IBD患者VTE发生率为7.6%,显著高于对照组的3.3%(P<0.0001)。
- IBD患者VTE年龄标化发病率为433/10万,对照组为184/10万。
- IBD患者VTE风险较对照人群增加2.36倍(95%CI 2.16-2.58)。
核心结论
- 尽管过去30年IBD管理有所进步,IBD患者VTE发生率仅缓慢下降,仍显著高于对照人群。
研究设计与样本
- 基于人群的曼尼托巴大学IBD流行病学数据库(1984-2018)队列研究,比较IBD患者与匹配对照的VTE发病率,并对IBD伴VTE患者进行多因素logistic回归分析。
主要发现
- IBD队列VTE发生率为7.6%,显著高于对照组的3.3%(P<0.0001)。
- IBD患者VTE年龄标化发病率为433/10万,对照组为184/10万;IBD vs 对照的发病率比为2.36(95%CI 2.16-2.58)。
- 克罗恩病VTE发生率(8.4%)高于溃疡性结肠炎(6.9%,P=0.0028)。
- 1985至2018年IBD患者VTE年发病率下降非常缓慢,年度百分比变化为-0.7%(P=0.0003)。
- 住院、高合并症负担、使用抗TNF抗体不足3年(截至VTE发生时)以及激素联合抗TNF抗体增加VTE风险。
临床怎么用
- 消化内科医生应持续重视IBD患者的VTE风险,尤其对住院、高合并症、近期使用抗TNF抗体不足3年或激素联合抗TNF治疗的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Venous thromboembolism (VTE) is known to be increased in inflammatory bowel disease (IBD). We aimed to determine whether rates of VTE in IBD have reduced over the past 30 years. METHODS: We used the population-based University of Manitoba IBD Epidemiology Database (1984-2018) to determine the incidence of VTE in IBD and the incidence rate ratio vs matched controls. In persons with IBD with and without VTE, we assessed for variables that were associated with an increased risk of VTE on multivariate logistic regression. RESULTS: The incidence of VTE in the IBD cohort was 7.6% which was significantly greater than in controls (3.3%, P < 0.0001). The overall age-standardized incidence rate of VTE was 433 per 100,000 in IBD and 184 per 100,000 in controls. The incidence of VTE was higher in Crohn's disease (8.4%) than in ulcerative colitis (6.9%, P = 0.0028). The incidence rate ratio in IBD vs controls was 2.36 (95% confidence interval 2.16-2.58). The increased risk was similar in males and females and in Crohn's disease compared with ulcerative colitis. The incidence rate among persons with IBD from 1985 to 2018 decreased very slowly, with annual percent change of -0.7% (P = 0.0003). Hospital admission, high comorbidity, use of antibodies to tumor necrosis factor for less than 3 years up until the time of the VTE, and the combination of steroid and antibodies to tumor necrosis factor increased the risk of VTE. DISCUSSION: Despite advancements in IBD management in the past 30 years, the rates of VTE have only been slowly decreasing and remain significantly increased compared with controls.
引用
- Bernstein CN, Nugent Z, Singh H, et al. Persistently High Rate of Venous Thromboembolic Disease in Inflammatory Bowel Disease: A Population-Based Study. Am J Gastroenterol. 2021. PMID: 33767104. doi:10.14309/ajg.0000000000001237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。